Literature DB >> 18722367

The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells.

Siang-Yo Lin1, Jun Yang, Allen D Everett, Charles V Clevenger, Mythili Koneru, Pravin J Mishra, Barton Kamen, Debabrata Banerjee, John Glod.   

Abstract

Bone marrow-derived mesenchymal stromal cells (MSCs) localize to solid tumors. Defining the signaling mechanisms that regulate this process is important in understanding the role of MSCs in tumor growth. Using a combination of chromatography and electrospray tandem mass spectrometry we have identified novel soluble signaling molecules that induce MSC chemotaxis present in conditioned medium of the breast carcinoma cell line MDA-MB231. Previous work has employed survey strategies using ELISA assay to identify known chemokines that promote MSC chemotaxis. While these studies provide valuable insights into the intercellular signals that impact MSC behavior, many less well-described, but potentially important soluble signaling molecules could be overlooked using these methods. Through the less directed method of column chromatography we have identified novel candidate MSC chemotactic peptides. Two proteins, cyclophilin B and hepatoma-derived growth factor were then further characterized and shown to promote MSC chemotaxis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18722367      PMCID: PMC2606107          DOI: 10.1016/j.yexcr.2008.07.028

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  53 in total

1.  Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells.

Authors:  Zongning Miao; Jun Jin; Lei Chen; Jianzhong Zhu; Wei Huang; Jidong Zhao; Hanguang Qian; Xueguang Zhang
Journal:  Cell Biol Int       Date:  2006-04-22       Impact factor: 3.612

2.  Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat.

Authors:  Kellie McFarlin; Xiaohua Gao; Yong Bo Liu; Deborah S Dulchavsky; David Kwon; Ali S Arbab; Mona Bansal; Yi Li; Michael Chopp; Scott A Dulchavsky; Subhash C Gautam
Journal:  Wound Repair Regen       Date:  2006 Jul-Aug       Impact factor: 3.617

3.  Hepatoma-derived growth factor is expressed after vascular injury in the rat and stimulates smooth muscle cell migration.

Authors:  Jill V Narron; Tamara D Stoops; Kurt Barringhaus; Martin Matsumura; Allen D Everett
Journal:  Pediatr Res       Date:  2006-04-26       Impact factor: 3.756

Review 4.  Regulation of protein function by glycosaminoglycans--as exemplified by chemokines.

Authors:  T M Handel; Z Johnson; S E Crown; E K Lau; A E Proudfoot
Journal:  Annu Rev Biochem       Date:  2005       Impact factor: 23.643

5.  Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC).

Authors:  Christian Schichor; Tobias Birnbaum; Nima Etminan; Oliver Schnell; Stefan Grau; Sabine Miebach; Karen Aboody; Claudio Padovan; Andreas Straube; Jörg-Christian Tonn; Roland Goldbrunner
Journal:  Exp Neurol       Date:  2006-03-29       Impact factor: 5.330

6.  Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads.

Authors:  I Kassis; L Zangi; R Rivkin; L Levdansky; S Samuel; G Marx; R Gorodetsky
Journal:  Bone Marrow Transplant       Date:  2006-05       Impact factor: 5.483

7.  Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy.

Authors:  Patrizia Mancuso; Marco Colleoni; Angelica Calleri; Laura Orlando; Patrick Maisonneuve; Giancarlo Pruneri; Alice Agliano; Aron Goldhirsch; Yuval Shaked; Robert S Kerbel; Francesco Bertolini
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

8.  The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation.

Authors:  Shyam Bhakta; Ping Hong; Omer Koc
Journal:  Cardiovasc Revasc Med       Date:  2006 Jan-Mar

Review 9.  The cyclophilins.

Authors:  Ping Wang; Joseph Heitman
Journal:  Genome Biol       Date:  2005-06-27       Impact factor: 13.583

10.  Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach.

Authors:  S M Zeisberger; B Odermatt; C Marty; A H M Zehnder-Fjällman; K Ballmer-Hofer; R A Schwendener
Journal:  Br J Cancer       Date:  2006-07-11       Impact factor: 7.640

View more
  21 in total

1.  Cyclophilin B as a co-regulator of prolactin-induced gene expression and function in breast cancer cells.

Authors:  Feng Fang; Jiamao Zheng; Traci L Galbaugh; Alyson A Fiorillo; Elizabeth E Hjort; Xianke Zeng; Charles V Clevenger
Journal:  J Mol Endocrinol       Date:  2010-03-17       Impact factor: 5.098

Review 2.  Mesenchymal stem cells in the pathogenesis and therapy of breast cancer.

Authors:  Christelle P El-Haibi; Antoine E Karnoub
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-12-21       Impact factor: 2.673

3.  Cyclophilin B expression is associated with in vitro radioresistance and clinical outcome after radiotherapy.

Authors:  Paul D Williams; Charles R Owens; Jaroslaw Dziegielewski; Christopher A Moskaluk; Paul W Read; James M Larner; Michael D Story; William A Brock; Sally A Amundson; Jae K Lee; Dan Theodorescu
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

Review 4.  Mesenchymal stem cell secretome and regenerative therapy after cancer.

Authors:  Ludovic Zimmerlin; Tea Soon Park; Elias T Zambidis; Vera S Donnenberg; Albert D Donnenberg
Journal:  Biochimie       Date:  2013-06-05       Impact factor: 4.079

5.  Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity.

Authors:  Emilie Mamessier; Aude Sylvain; Marie-Laure Thibult; Gilles Houvenaeghel; Jocelyne Jacquemier; Rémy Castellano; Anthony Gonçalves; Pascale André; François Romagné; Gilles Thibault; Patrice Viens; Daniel Birnbaum; François Bertucci; Alessandro Moretta; Daniel Olive
Journal:  J Clin Invest       Date:  2011-08-15       Impact factor: 14.808

6.  Spontaneous formation of tumorigenic hybrids between breast cancer and multipotent stromal cells is a source of tumor heterogeneity.

Authors:  Germana Rappa; Javier Mercapide; Aurelio Lorico
Journal:  Am J Pathol       Date:  2012-04-27       Impact factor: 4.307

Review 7.  Mesenchymal stem cells in tumor development: emerging roles and concepts.

Authors:  Benjamin G Cuiffo; Antoine E Karnoub
Journal:  Cell Adh Migr       Date:  2012-05-01       Impact factor: 3.405

8.  Differential mechanical response of mesenchymal stem cells and fibroblasts to tumor-secreted soluble factors.

Authors:  Daniel J McGrail; Deepraj Ghosh; Nhat D Quach; Michelle R Dawson
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

9.  The Microenvironmental Effect in the Progression, Metastasis, and Dormancy of Breast Cancer: A Model System within Bone Marrow.

Authors:  Bobby Y Reddy; Philip K Lim; Kimberly Silverio; Shyam A Patel; Brian Wong Won; Pranela Rameshwar
Journal:  Int J Breast Cancer       Date:  2012-02-06

10.  Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells.

Authors:  M Walter; S Liang; S Ghosh; P J Hornsby; R Li
Journal:  Oncogene       Date:  2009-06-01       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.